# Humacyte, Inc.: filings

HUMA · Nasdaq · CIK 1818382 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/huma.md) · [Financials](/companies/huma/financials.md) · [Filings](/companies/huma/filings.md) · [Insiders](/companies/huma/insiders.md)

## Reports and events: 138 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 204, 8-K 79, 3 31, 144 24, 10-Q 18, 424B3 15, 425 13, SC 13D/A 12, CORRESP 11, UPLOAD 11, EFFECT 10, SCHEDULE 13D/A 8, 10-K 6, 424B5 6, DEF 14A 5, DEFA14A 4, S-3 4, S-4/A 4, S-8 4, 424B7 3, POS AM 3, S-1/A 3, SC 13D 3, SC 13G 3, 25-NSE 2, PRE 14A 2, S-1 2, SC 13G/A 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, S-4 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 20:05 ET | [8-K](/filings/0001818382-26-000011.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818382-26-000011 |
| 2026-08-18 | 13:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-098152.md) | Ownership report, active investor, amended | 0001104659-26-098152 |
| 2026-08-12 | 20:45 ET | [10-Q](/filings/0001193125-26-347022.md) | Quarterly report, period 2026-06-30 | 0001193125-26-347022 |
| 2026-08-12 | 11:03 ET | [8-K](/filings/0001104659-26-094440.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094440 |
| 2026-07-31 | 21:00 ET | [8-K](/filings/0001104659-26-089281.md) | 3.01 Delisting notice | 0001104659-26-089281 |
| 2026-07-13 | 21:25 ET | [SCHEDULE 13D/A](/filings/0001104659-26-083164.md) | Ownership report, active investor, amended | 0001104659-26-083164 |
| 2026-06-15 | 13:53 ET | [SCHEDULE 13D/A](/filings/0001104659-26-073827.md) | Ownership report, active investor, amended | 0001104659-26-073827 |
| 2026-06-11 | 20:43 ET | [8-K](/filings/0001104659-26-072980.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-072980 |
| 2026-06-10 | 20:34 ET | [8-K](/filings/0001104659-26-072382.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-072382 |
| 2026-06-09 | 20:30 ET | [8-K](/filings/0001104659-26-071862.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-071862 |
| 2026-06-05 | 20:30 ET | [8-K](/filings/0001104659-26-071000.md) | 8.01 Other events | 0001104659-26-071000 |
| 2026-05-13 | 20:30 ET | [10-Q](/filings/0001193125-26-221755.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221755 |
| 2026-05-08 | 20:30 ET | [8-K](/filings/0001104659-26-057974.md) | 3.01 Delisting notice | 0001104659-26-057974 |
| 2026-04-28 | 20:52 ET | [DEF 14A](/filings/0001193125-26-187449.md) | Proxy statement, period 2026-04-28 | 0001193125-26-187449 |
| 2026-04-27 | 10:01 ET | [SCHEDULE 13D/A](/filings/0001104659-26-048819.md) | Ownership report, active investor, amended | 0001104659-26-048819 |
| 2026-04-24 | 12:09 ET | [8-K](/filings/0001104659-26-048164.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-048164 |
| 2026-03-27 | 20:45 ET | [10-K](/filings/0001818382-26-000004.md) | Annual report, period 2025-12-31 | 0001818382-26-000004 |
| 2026-03-24 | 10:02 ET | [SCHEDULE 13D/A](/filings/0001104659-26-033489.md) | Ownership report, active investor, amended | 0001104659-26-033489 |
| 2026-03-19 | 20:33 ET | [8-K](/filings/0001104659-26-032116.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-032116 |
| 2026-03-19 | 12:25 ET | [8-K](/filings/0001104659-26-031780.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-031780 |
| 2026-01-09 | 16:42 ET | [SCHEDULE 13D/A](/filings/0001104659-26-002371.md) | Ownership report, active investor, amended | 0001104659-26-002371 |
| 2025-12-16 | 22:30 ET | [8-K](/filings/0001104659-25-121674.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-121674 |
| 2025-12-15 | 21:52 ET | [8-K](/filings/0001104659-25-121214.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-121214 |
| 2025-12-15 | 14:12 ET | [8-K](/filings/0001104659-25-120915.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-120915 |
| 2025-11-26 | 22:01 ET | [8-K](/filings/0001104659-25-116476.md) | 1.02 Termination of a material agreement | 0001104659-25-116476 |
| 2025-11-12 | 21:46 ET | [10-Q](/filings/0001818382-25-000132.md) | Quarterly report, period 2025-09-30 | 0001818382-25-000132 |
| 2025-11-12 | 12:06 ET | [8-K](/filings/0001104659-25-109718.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109718 |
| 2025-10-16 | 21:25 ET | [SCHEDULE 13D/A](/filings/0001104659-25-100146.md) | Ownership report, active investor, amended | 0001104659-25-100146 |
| 2025-10-07 | 21:31 ET | [8-K](/filings/0001104659-25-097591.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-097591 |
| 2025-09-18 | 01:45 ET | [8-K](/filings/0001104659-25-090963.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-090963 |
| 2025-08-11 | 21:01 ET | [10-Q](/filings/0001818382-25-000125.md) | Quarterly report, period 2025-06-30 | 0001818382-25-000125 |
| 2025-08-11 | 11:04 ET | [8-K](/filings/0001818382-25-000122.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-25-000122 |
| 2025-06-11 | 20:08 ET | [8-K](/filings/0001818382-25-000080.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001818382-25-000080 |
| 2025-05-22 | 19:23 ET | [SCHEDULE 13D/A](/filings/0001104659-25-051950.md) | Ownership report, active investor, amended | 0001104659-25-051950 |
| 2025-05-13 | 21:11 ET | [10-Q](/filings/0001818382-25-000076.md) | Quarterly report, period 2025-03-31 | 0001818382-25-000076 |
| 2025-05-13 | 11:36 ET | [8-K](/filings/0001818382-25-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-25-000073 |
| 2025-04-29 | 20:04 ET | [DEF 14A](/filings/0001818382-25-000066.md) | Proxy statement, period 2025-06-10 | 0001818382-25-000066 |
| 2025-04-18 | 21:36 ET | [8-K](/filings/0001818382-25-000061.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818382-25-000061 |
| 2025-03-31 | 20:31 ET | [10-K](/filings/0001818382-25-000034.md) | Annual report, period 2024-12-31 | 0001818382-25-000034 |
| 2025-03-28 | 11:55 ET | [8-K](/filings/0001818382-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-25-000030 |
| 2025-03-27 | 21:17 ET | [8-K](/filings/0001104659-25-028830.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028830 |
| 2025-03-26 | 20:48 ET | [8-K](/filings/0001104659-25-028274.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028274 |
| 2025-03-25 | 20:02 ET | [8-K](/filings/0001104659-25-027762.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-027762 |
| 2024-12-20 | 21:25 ET | [8-K](/filings/0001818382-24-000227.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000227 |
| 2024-11-20 | 00:10 ET | [SC 13D/A](/filings/0001818382-24-000210.md) | Ownership report, active investor, amended | 0001818382-24-000210 |
| 2024-11-18 | 21:10 ET | [SC 13D/A](/filings/0001104659-24-120135.md) | Ownership report, active investor, amended | 0001104659-24-120135 |
| 2024-11-14 | 21:30 ET | [8-K](/filings/0001104659-24-119013.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-119013 |
| 2024-11-08 | 21:13 ET | [10-Q](/filings/0001818382-24-000199.md) | Quarterly report, period 2024-09-30 | 0001818382-24-000199 |
| 2024-11-08 | 13:04 ET | [8-K](/filings/0001818382-24-000197.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-24-000197 |
| 2024-10-28 | 20:07 ET | [8-K](/filings/0001818382-24-000192.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000192 |

Page 1 of 3. [Older](/companies/huma/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.